Stonepine Capital Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Stonepine Capital Management, LLC
- $124 Billion
- Q4 2024
A detailed history of Stonepine Capital Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 500,000 shares of MIST stock, worth $990,000. This represents 0.95% of its overall portfolio holdings.
Number of Shares
500,000
Previous 999,790
49.99%
Holding current value
$990,000
Previous $1.52 Billion
22.35%
% of portfolio
0.95%
Previous 0.96%
Shares
4 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
25.1MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$9.84 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$5.35 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$5.26 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.96 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$3.96 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $59.4M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...